Posted on 1/04/2021
Worthing, UK – Rayner, the only British manufacturer of intraocular lenses (IOLs), has been successfully awarded Authorised Economic Operator (AEO) status by HM Revenue & Customs. AEO status is an internationally recognised quality mark indicating that Rayner’s role in the international supply chain is secure and that its customs controls and procedures are efficient and
Posted on 26/03/2021
New York, USA, March 26, 2021 – RayOne EMV, a new fully preloaded non-diffractive IOL, has received FDA approval. RayOne EMV was developed in collaboration with world renowned surgeon Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons. “I collaborated with Rayner on bringing to market RayOne EMV, an exciting new product
Posted on 21/01/2021
Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical Corp will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. Rayner Surgical Corp has recently had the RayOne Aspheric
Posted on 22/10/2020
Worthing (UK) – Rayner, the manufacturer of the world’s first intraocular lens (IOL) and winner of the 2020 Queen’s Award for Enterprise (Innovation), announced today the launch of their updated web-based Premium IOL Calculator, Raytrace. Developed in line with surgeon feedback, the new Raytrace version 3.5 includes the following improvements: Inclusion of Posterior Corneal Astigmatism
Posted on 21/09/2020
Rayner set to launch RayOne EMV in early October Worthing, UK, September 21st, 2020 – Rayner has announced the upcoming launch of RayOne EMV: a new fully preloaded non-diffractive IOL solution designed specifically to enhance patient outcomes achieved with monovision. Enhanced range of vision Developed in collaboration with Professor Graham Barrett, president of the Australasian
Posted on 22/07/2020
For immediate release Worthing, UK, July 22, 2020 – Rayner, the only UK manufacturer of Intraocular Lenses (IOLs) for treating cataracts and a winner of the 2020 Queen’s Awards for Enterprise (Innovation), announced today that changes to their manufacturing and packaging procedures will reduce CO2 greenhouse gas emissions by more than 800 tonnes over the
Posted on 4/06/2020
Rayner hosted its first surgeon clinical education webinar on 27 May 2020, with attendees from over 47 countries. Over the course of one hour, the three presenters spoke about returning to clinic (including associated safety precautions), their experience with premium trifocal IOLs, and the utilisation of contactless telehealth. The webinar was concluded with a busy
Posted on 22/05/2020
Wednesday 27th May (1 hour) Join an international panel of expert speakers as they share their experiences with premium trifocal intraocular lenses (IOLs), and discuss the importance of Patient Reported Outcomes (PROs). The speakers will also talk about returning to clinic after COVID-19. The webinar will last 1 hour (includes 15-minute Question & Answer session).
Posted on 18/05/2020
In order to serve hospitals, surgeons and patients around the world in need of cataract surgery and ophthalmic treatment, Rayner has today opened its commercial office. This means that our customer service, technical support and logistics teams are available to serve our customers as normal. Our factory never stopped producing our award-winning intraocular lenses meaning
Posted on 14/05/2020
Worthing (UK) – Rayner, the only UK manufacturer of Intraocular Lenses (IOLs) for treating cataracts and last month revealed as a winner of the 2020 Queen’s Awards for Enterprise (Innovation) for its RayOne IOL injector system, announced today that it substantially increased IOL production levels between January and April, despite NHS elective surgery being postponed